HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$45.95
Day range
$41.50 - $45.45
Year range
$16.94 - $53.27
Market cap
2.72B USD
Avg Volume
368.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.74M | -20.88% |
Operating expense | 15.46M | 9.45% |
Net income | -62.49M | -18.20% |
Net profit margin | -1.67K | -49.38% |
Earnings per share | -0.82 | 8.89% |
EBITDA | -70.14M | -23.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.97M | 53.70% |
Total assets | 1.03B | 87.34% |
Total liabilities | 141.91M | -9.52% |
Total equity | 892.93M | — |
Shares outstanding | 64.77M | — |
Price to book | 3.33 | — |
Return on assets | -19.38% | — |
Return on capital | -20.56% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -62.49M | -18.20% |
Cash from operations | -50.19M | -58.59% |
Cash from investing | -157.68M | -360.58% |
Cash from financing | 250.92M | 121,904.85% |
Net change in cash | 43.05M | 50.21% |
Free cash flow | -27.37M | -20.20% |
About
Founded
2015
Headquarters
Website
Employees
184
